# Deanxit and Rivotril in Tinnitus Patients

> **NCT00841230** · PHASE4 · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 50 (estimated)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** Deanxit
- **DRUG:** Lactose placebo

## Key facts

- **NCT ID:** NCT00841230
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841230, "Deanxit and Rivotril in Tinnitus Patients". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00841230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*